The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A Unique Resource for Defining the “Molecular Histology” of the Breast

“Molecular histology” of the breast may be conceptualized as encompassing the normative ranges of histologic structure and marker expression in normal breast tissues in relation to a woman's age and life experiences. Studies of molecular histology can aid our understanding of early events in breast carcinogenesis and provide data for comparison with diseased breast tissues. Until recently, lack of epidemiologically annotated, optimally prepared normal breast tissues obtained from healthy women presented a barrier to breast cancer research. The Komen Tissue Bank at Indiana University (Indianapolis, IN) is a unique biorepository that was developed to overcome this limitation. The Bank enrolls healthy donors who provide questionnaire data, blood, and up to four breast biopsies, which are prepared as both formalin-fixed, paraffin-embedded and frozen tissues. The resource is accessible to researchers worldwide through a proposal submission, review, and approval process. As of November 2010, the Bank had collected specimens and information from 1,174 donors. In this review, we discuss the importance of studying normal breast tissues, assess the strengths and limitations of studying normal tissues obtained from different sources, and summarize the features of the Komen Tissue Bank. As research projects are completed, results will be posted on the Bank's website. Cancer Prev Res; 5(4); 528–35. ©2012 AACR.

[1]  J. Russo,et al.  Molecular basis of pregnancy-induced breast cancer protection , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  A. Ashworth,et al.  Pregnancy and the risk of breast cancer. , 2007, Endocrine-related cancer.

[3]  V Shane Pankratz,et al.  Association between mammographic density and age-related lobular involution of the breast. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Bingshu E. Chen,et al.  Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions , 2007, Cancer Causes & Control.

[5]  R. Vierkant,et al.  Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues , 2012, Breast Cancer Research and Treatment.

[6]  Jason R. Pirone,et al.  Activation of Host Wound Responses in Breast Cancer Microenvironment , 2009, Clinical Cancer Research.

[7]  J. Russo,et al.  Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices , 2007, Menopause.

[8]  G. Koch,et al.  Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. , 1997, Pediatrics.

[9]  H. Juhl Preanalytical aspects: A neglected issue , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[10]  C. Benz Impact of aging on the biology of breast cancer. , 2005, Critical reviews in oncology/hematology.

[11]  D. Radisky,et al.  Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical Studies , 2009, Journal of Mammary Gland Biology and Neoplasia.

[12]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[13]  C R Key,et al.  Biologic characteristics of interval and screen-detected breast cancers. , 2000, Journal of the National Cancer Institute.

[14]  Timothy J. Yeatman,et al.  Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue , 2006, Clinical Cancer Research.

[15]  T. Stein,et al.  Microenvironment of the Involuting Mammary Gland Mediates Mammary Cancer Progression , 2007, Journal of Mammary Gland Biology and Neoplasia.

[16]  D. G. Hoel,et al.  ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.

[17]  A. Paterson,et al.  Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.

[18]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[19]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[20]  B. Geramizadeh,et al.  Frequency of Clinically Occult Intraepithelial and Invasive Neoplasia in Reduction Mammoplasty Specimens: A Study of 516 Cases , 2008, International journal of surgical pathology.

[21]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[22]  W. Foulkes,et al.  A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  Antonio de las Morenas,et al.  Gene Expression Profiles of Estrogen Receptor–Positive and Estrogen Receptor–Negative Breast Cancers Are Detectable in Histologically Normal Breast Epithelium , 2010, Clinical Cancer Research.

[24]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[25]  M. Meguid,et al.  Estrogen receptor expression in benign breast epithelium and breast cancer risk. , 1998, Journal of the National Cancer Institute.

[26]  S. Hilsenbeck,et al.  Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer , 2005, Breast Cancer Research.

[27]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[28]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[29]  T. Sørensen,et al.  Growth patterns and the risk of breast cancer in women. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[30]  Melissa C. Greven,et al.  Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women , 2010, Epigenetics.

[31]  B. Angus,et al.  A study of interval breast cancer within the NHS breast screening programme , 2000, Journal of clinical pathology.

[32]  M. Sherman,et al.  Recent trends in breast cancer among younger women in the United States. , 2008, Journal of the National Cancer Institute.

[33]  Marvin Zelen,et al.  Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.

[34]  T. Longacre,et al.  A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle , 1986, The American journal of surgical pathology.

[35]  J. Sloane,et al.  Oestrogen receptor expression in the normal and pre‐cancerous breast , 1999, The Journal of pathology.